Coherus BioSciences Stock (NASDAQ: CHRS) stock price, news, charts, stock research, profile.
You can purchase shares of Coherus BioSciences (NASDAQ:CHRS) through any online brokerage.
Other companies in Coherus BioSciences’s space includes: Zura Bio (NASDAQ:ZURA), Renovaro (NASDAQ:RENB), Innate Pharma (NASDAQ:IPHA), Adaptimmune Therapeutics (NASDAQ:ADAP) and Tevogen Bio Holdings (NASDAQ:TVGN).
Coherus BioSciences has a consensus price target of $9.06.
The stock price for Coherus BioSciences (NASDAQ: CHRS) is $1.45 last updated December 24, 2024 at 3:53 PM EST.
There are no upcoming dividends for Coherus BioSciences.
Coherus BioSciences’s Q4 earnings are confirmed for Wednesday, March 12, 2025.
There is no upcoming split for Coherus BioSciences.
Coherus BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.